Abbreviations CVE: Cardiovascular event EHR: Electronic health record GLP-1RA: Glucagon-like peptide-1 receptor agonist MACE: Major adverse cardiovascular events NAFLD: Non-alcoholic fatty liver disease NASH: Non-alcoholic steatohepatitis PCI: Percutaneous coronary intervention PSM: Propensity score matching SGLT2: Sodiumglucose cotransporter 2 SMD: Standardised mean difference TG: Triacylglycerol References Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes
Safety Considerations and Side Effects of GLP-1 Agonists Whilst GLP-1 receptor agonists are generally well-tolerated, patients and prescribers must be aware of potential adverse effects and important safety considerations
The long view, because menopause and GLP-1 progress often move slower than people expect
Explore More Health Resources STORIES from the Heart
Trying to save that small amount by buying without a prescription creates unnecessary risk
They dont just mask hunger